Drug List Changes

  • Effective July 01, 2019

    Formulary Changes to the Preferred B2 Drug List

    Drug Name Description of Change Cost-effective Alternatives*
    Advair Diskus inhalerNo longer coveredfluticasone-salmeterol inhaler
    Emend capsuleNo longer coveredaprepitant capsule
    Fareston tabletNo longer coveredtoremifene tablet
    Mestinon syrupNo longer coveredpyridostigmine syrup
    Renagel tabletNo longer coveredsevelamer hydrochloride tablet
    Sensipar tabletNo longer coveredcinacalcet tablet
    Suboxone filmNo longer coveredbuprenorphine/naloxone film
    Zovirax 5% creamNo longer coveredacyclovir 5% cream

    Formulary Changes to the Preferred B3 and B4 Drug Lists

    Drug Name Description of Change Cost-effective Alternatives*
    Advair Diskus inhalerMoving to a higher levelfluticasone-salmeterol inhaler
    Emend capsuleMoving to a higher levelaprepitant capsule
    Fareston tabletMoving to a higher leveltoremifene tablet
    Mestinon syrupMoving to a higher levelpyridostigmine syrup
    Renagel tabletMoving to a higher levelsevelamer hydrochloride tablet
    Sensipar tabletMoving to a higher levelcinacalcet tablet
    Suboxone filmMoving to a higher levelbuprenorphine/naloxone film
    Zovirax 5% creamMoving to a higher levelacyclovir 5% cream

    Formulary Changes to the E4 Drug List

    Drug Name Description of Change Cost-effective Alternatives*
    Advair Diskus inhalerMoving to a higher levelfluticasone-salmeterol inhaler
    Emend capsuleMoving to a higher levelaprepitant capsule
    Fareston tabletMoving to a higher leveltoremifene tablet
    Mestinon syrupMoving to a higher levelpyridostigmine syrup
    Suboxone filmMoving to a higher levelbuprenorphine/naloxone film

    Formulary Changes to the M1, M2 and M4 (2019) Drug Lists

    Drug Name Description of Change Cost-effective Alternatives*
    Advair Diskus inhalerNo longer coveredfluticasone-salmeterol inhaler
    Emend capsuleNo longer coveredaprepitant capsule
    Fareston tabletNo longer coveredtoremifene tablet
    Mestinon syrupNo longer coveredpyridostigmine syrup
    Ranexa extended-release tabletNo longer coveredranolazine extended-release tablet
    Rapamune solutionNo longer coveredsirolimus solution
    Remodulin vialNo longer coveredtreprostinil vial
    Renagel tabletNo longer coveredsevelamer hydrochloride tablet
    Sabril tabletNo longer coveredvigabatrin tablet
    Sensipar tabletNo longer coveredcinacalcet tablet
    Suboxone filmNo longer coveredbuprenorphine/naloxone film
    Tekturna tabletNo longer coveredaliskiren tablet

    Formulary Changes to the M1, M2 and M4 (2018) Drug Lists

    Drug Name Description of Change Cost-effective Alternatives*
    Advair Diskus inhalerNo longer coveredfluticasone-salmeterol inhaler
    Emend capsuleNo longer coveredaprepitant capsule
    Fareston tabletNo longer coveredtoremifene tablet
    Mestinon syrupNo longer coveredpyridostigmine syrup
    Ranexa extended-release tabletNo longer coveredranolazine extended-release tablet
    Rapamune solutionNo longer coveredsirolimus solution
    Remodulin vialNo longer coveredtreprostinil vial
    Renagel tabletNo longer coveredsevelamer hydrochloride tablet
    Sabril tabletNo longer coveredvigabatrin tablet
    Sensipar tabletNo longer coveredcinacalcet tablet
    Solodyn extended-release tabletNo longer coveredminocycline extended-release tablet
    Suboxone filmNo longer coveredbuprenorphine/naloxone film
    Tekturna tabletNo longer coveredaliskiren tablet
    Zovirax 5% creamNo longer coveredacyclovir 5% cream

    Formulary Changes to the Select C4 Drug List

    Drug Name Description of Change Cost-effective Alternatives*
    Advair Diskus inhaler Moving to a higher levelfluticasone-salmeterol inhaler
    Fareston tabletMoving to a higher leveltoremifene tablet

    *These drugs have been selected by an independent group of experts made up of doctors and pharmacists. This group reviews drugs to see how well they work relative to their cost. They also compare their effectiveness to similar drugs used to treat the same condition. Please talk with your doctor to see if these new options are right for you.